Hikal gets nod to raise Rs 375 crore through NCDs

14 Feb 2022 Evaluate

Hikal has received approval to raise Rs 375 crore through 3750 Unrated, unlisted, secured, redeemable, Non-Convertible Debentures (NCDs) on private placement basis. Date of maturity will be 8 years from the date of allotment. The Board of Directors of the Company at its meeting held on February 14, 2022, has approved the same.

Hikal is a leading manufacturer and supplier of API's and intermediates globally.

Hikal Share Price

390.75 3.10 (0.80%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.